Alpla and Inden pharma form joint venture
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
Subscribe To Our Newsletter & Stay Updated